Internal Medicine, Rheumatology · Katy, TX
NPI
1215376132
Since 2013
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2630 N Mason Rd, Suite A2
Katy, TX, 77449
Phone (281) 712-8360
Groups this clinician bills Medicare through
Medicare paid, 2024
$705K
46,258 services
Medicare patients, 2024
109
Average age 74
Drug cost, 2024
$822K
1,005 prescriptions
Company payments, 2025
$413
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aman S Kugasia was code 96401 (chemotherapy administration), 143 times for 17 patients. In total Aman S Kugasia billed 46,258 services in 28 codes, and Medicare paid $705K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96401 Chemotherapy Administration | Office | 143 | 17 | $56.60 | $8,094 |
| 99214 Office E&M - Established | Office | 132 | 63 | $96.80 | $13K |
| 96413 Chemotherapy Administration | Office | 77 | 13 | $102.14 | $7,865 |
| 99213 Office E&M - Established | Office | 68 | 51 | $64.84 | $4,409 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 64 | 11 | $0.75 | $47.89 |
| 99204 Office E&M - New | Office | 22 | 22 | $123.39 | $2,715 |
| 99203 Office E&M - New | Office | 19 | 19 | $84.96 | $1,614 |
By year: 2022 $291K for 34,768 services; 2023 $235K for 25,767 services; 2024 $705K for 46,258 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aman S Kugasia prescribed most often to Medicare patients was Prednisone, with 132 prescriptions and refills. In total Aman S Kugasia wrote 1,005 Medicare prescriptions that cost $822K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 132 | 205 | 60 | $746 |
| Methotrexate Methotrexate Sodium | 125 | 300 | 45 | $4,282 |
| Meloxicam Generic | 78 | 122 | 30 | $245 |
| Tramadol Hcl Generic | 54 | 54 | 18 | $150 |
| Hydroxychloroquine Sulfate Generic | 51 | 121 | 20 | $1,997 |
| Gabapentin Generic | 47 | 99 | 22 | $590 |
| Allopurinol Generic | 40 | 106 | 16 | $424 |
| Alendronate Sodium Generic | 39 | 91 | 18 | $301 |
| Enbrel Sureclick Etanercept | 38 | 38 | Under 11 | $298K |
| Leflunomide Generic | 33 | 83 | 13 | $1,818 |
| Pregabalin Generic | 30 | 50 | 13 | $1,104 |
| Duloxetine Hcl Generic | 25 | 41 | Under 11 | $655 |
| Folic Acid Generic | 24 | 66 | 12 | $228 |
| Diclofenac Sodium Generic | 19 | 25 | Under 11 | $292 |
| Celecoxib Generic | 16 | 32 | 11 | $729 |
Brand drugs: - claims; generic drugs: 885 claims; opioid claims: 57.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aman S Kugasia $413 ($413 in general payments such as food, travel and fees) from 8 companies. The largest payer was Amgen Inc. with $260.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.